The compiled results in Table 1 indicate that some functional polymorphisms affecting the enzymatic activities of CYP2D6, CYP3A5, CYP2C8, CYP2C19, SULT1A1, or UGT2B15 could significantly affect breast cancer outcomes. The gene discussed is CYP3A5; the disease is breast carcinoma.